Covid-19: monitoring of patients’ laboratory data during a 90-day length of hospital stay
Covid-19: acompanhamento de dados laboratoriais de pacientes durante 90 dias de internação
DOI:
https://doi.org/10.34119/bjhrv5n6-169Keywords:
SARS Coronavirus, laboratory testes Covid-19, biochemical analysisAbstract
Background: In March 2020, COVID-19 was declared a pandemic. In this study, patients were selected through the chest HRCT diagnosis. Laboratory tests such as blood count, fibrinogen, D-dimer, AST, ALT, troponin, LDH, albumin, CRP, electrolytes and ferritin were analyzed. Aims: To monitor the laboratory evolution of COVID-19 in patients during hospitalization. Method: Of 115 patients, 93 were selected and analyzed every three days for 90 days. Data were analyzed using the IBM, SPSS, Statistics for Windows, 23.0 software. Results: 34.4% were female, and 65.6% male; Hct and Hb dropped after the 13th day of hospitalization; leukocyte levels remained up to 15,000, increasing to >20,000 after the 55th day of hospitalization; lymphopenia occurred in 10 to 15% of the patients, with increased eosinophils; platelet levels decreased at the end of hospitalization. Fibrinogen, D-dimer, LDH, CRP and ferritin levels increased throughout the hospitalization period. Urea and creatinine increased slightly from the 30th day onwards. There were no alterations in PTA, troponin, chlorine, potassium and albumin levels, with a decrease throughout the hospitalization period. Conclusion: Knowledge of the behavior of laboratory tests together with the disease evolution give support to the clinical and therapeutic management of COVID-19.
References
Xiang, N., Havers, F., Chen, T., Song, Y., Tu, W., Li, L., Cao, Y., Liu, B., Zhou, L., Meng, L., Hong, Z., Wang, R., Niu, Y., Yao, J., Liao, K., Jin, L., Zhang, Y., Li, Q., Widdowson, M. A., & Feng, Z. (2013). Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013. Emerging infectious diseases, 19(11), 1784–1790. https://doi.org/10.3201/eid1911.130865.
Whitworth J. (2020). COVID-19: a fast evolving pandemic. Transactions of the Royal Society of Tropical Medicine and Hygiene, 114(4), 241–248. https://doi.org/10.1093/trstmh/traa025.
Nishiura, H., Jung, S. M., Linton, N. M., Kinoshita, R., Yang, Y., Hayashi, K., ... & Akhmetzhanov, A. R. (2020). The extent of transmission of novel coronavirus in Wuhan, China, 2020.
Tang, B., Bragazzi, N. L., Li, Q., Tang, S., Xiao, Y., & Wu, J. (2020). An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infectious disease modelling, 5, 248-255.
Wang, W., Tang, J., & Wei, F. (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. Journal of medical virology, 92(4), 441-447.
Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 323(13), 1239-1242.
Nissen, C. B., Sciascia, S., de Andrade, D., Atsumi, T., Bruce, I. N., Cron, R. Q., ... & Schreiber, K. (2021). The role of antirheumatics in patients with COVID-19. The Lancet Rheumatology.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cao, B. (2020). Clinical characteristics of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Singhal, T. (2020). A review of coronavirus disease-2019 (COVID-19). The indian journal of pediatrics, 87(4), 281-286.
World Health Organization. Weekly epidemiological update on COVID-19. [cited 2021 May 11]. Available from: https://www.who.int/publications/m/item/weekly - epidemiological - update - on - covid - 19. May, 2021.
World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. Interim Guidance. March, 2020.
Naserghandi, A., Allameh, S. F., & Saffarpour, R. (2020). All about COVID-19 in brief. New microbes and new infections, 35.
Chate, R. C., Fonseca, E. K. U. N., Passos, R. B. D., Teles, G. B. D. S., Shoji, H., & Szarf, G. (2020). Apresentação tomográfica da infecção pulmonar na COVID-19: experiência brasileira inicial. Jornal Brasileiro de Pneumologia, 46.
Lei, J., Li, J., Li, X., & Qi, X. (2020). CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 295(1), 18-18.
Cantero, M.T.R. (2020). Health statistics and invisibility by sex and gender during the COVID-19 epidemic. Gaceta sanitaria, 35(1), 95-98.
Umakanthan, S., Sahu, P., Ranade, A. V., Bukelo, M. M., Rao, J. S., Abrahao-Machado, L. F., ... & Dhananjaya, K. V. (2020). Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgraduate medical journal, 96(1142), 753-758.
Ministério da Saúde. Secretaria de Vigilância em Saúde Doença pelo Coronavírus- COVID-19. Versão 1. April, 2021.
Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., & Nabipour, I. (2020). COVID-19 cytokine storm: The anger of inflammation. Cytokine, 133, 155151.
Cavezzi, A., Troiani, E., & Corrao, S. (2020). COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clinics and practice, 10(2), 24-30.
Artaza, J. R., Carbia, C. D., Ceballo, M. F., & Diaz, N. B. (1999). Red cell distribution width (RDW): its use in the characterization of microcytic and hypochromic anemias. Medicina, 59(1), 17-22.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.
Lindsley, A. W., Schwartz, J. T., & Rothenberg, M. E. (2020). Eosinophil responses during COVID-19 infections and coronavirus vaccination. Journal of Allergy and Clinical Immunology, 146(1), 1-7.
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020). Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19). Platelets, 31(5), 627-632.
Haematology, T. L. (2020). COVID-19 coagulopathy: an evolving story. The Lancet. Haematology, 7(6), 425.
Mazzeffi, M. A., Chow, J. H., & Tanaka, K. (2021). COVID-19 associated hypercoagulability: manifestations, mechanisms, and management. Shock (Augusta, Ga.), 55(4), 465.
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., ... & Zheng, C. (2020). Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology.
Zhang, J. J., Dong, X., Cao, Y. Y., Yuan, Y. D., Yang, Y. B., Yan, Y. Q., ... & Gao, Y. D. (2020). Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 75(7), 1730-1741.
Mardani, R., Vasmehjani, A. A., Zali, F., Gholami, A., Nasab, S. D. M., Kaghazian, H., ... & Ahmadi, N. (2020). Laboratory parameters in detection of COVID-19 patients with positive RT-PCR; a diagnostic accuracy study. Archives of academic emergency medicine, 8(1).
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., ... & Huang, C. (2020). Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology, 5(7), 802-810.
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., ... & Lu, Z. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology, 5(7), 811-818.
Henry, B. M., De Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020). Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM), 58(7), 1021-1028.
Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020 May;57(3):262-265. doi: 10.1177/0004563220922255. Epub 2020 May 3. PMID: 32266828; PMCID: PMC8173320.
Sarvazad H, Cahngaripour SH, Eskandari Roozbahani N, Izadi B. Evaluation of electrolyte status of sodium, potassium and magnesium, and fasting blood sugar at the initial admission of individuals with COVID-19 without underlying disease in Golestan Hospital, Kermanshah. New Microbes New Infect. 2020 Nov 7;38:100807. doi: 10.1016/j.nmni.2020.100807. PMID: 33294198; PMCID: PMC7701326.
Habib, H. M., Ibrahim, S., Zaim, A., & Ibrahim, W. H. (2021). The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomedicine & Pharmacotherapy, 111228.
